메뉴 건너뛰기




Volumn 22, Issue 3, 2014, Pages 547-553

Effective intravenous therapy for neurodegenerative disease with a therapeutic enzyme and a peptide that mediates delivery to the brain

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; DRUG CARRIER; K16APOE; LOW DENSITY LIPOPROTEIN RECEPTOR; RECOMBINANT DIPEPTIDYL PEPTIDASE I; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

EID: 84895455959     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2013.267     Document Type: Article
Times cited : (46)

References (34)
  • 1
    • 0030866233 scopus 로고    scopus 로고
    • Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis
    • Sleat, DE, Donnelly, RJ, Lackland, H, Liu, CG, Sohar, I, Pullarkat, RK et al. (1997). Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis. Science 277: 1802-1805.
    • (1997) Science , vol.277 , pp. 1802-1805
    • Sleat, D.E.1    Donnelly, R.J.2    Lackland, H.3    Liu, C.G.4    Sohar, I.5    Pullarkat, R.K.6
  • 2
    • 0026539541 scopus 로고
    • Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease)
    • Palmer, DN, Fearnley, IM, Walker, JE, Hall, NA, Lake, BD, Wolfe, LS et al. (1992). Mitochondrial ATP synthase subunit c storage in the ceroid-lipofuscinoses (Batten disease). Am J Med Genet 42: 561-567.
    • (1992) Am J Med Genet , vol.42 , pp. 561-567
    • Palmer, D.N.1    Fearnley, I.M.2    Walker, J.E.3    Hall, N.A.4    Lake, B.D.5    Wolfe, L.S.6
  • 3
    • 77956060447 scopus 로고    scopus 로고
    • The birth prevalence of lysosomal storage disorders in the Czech Republic: Comparison with data in different populations
    • Poupetová, H, Ledvinová, J, Berná, L, Dvoráková, L, Kozich, V and Elleder, M (2010). The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis 33: 387-396.
    • (2010) J Inherit Metab Dis , vol.33 , pp. 387-396
    • Poupetová, H.1    Ledvinová, J.2    Berná, L.3    Dvoráková, L.4    Kozich, V.5    Elleder, M.6
  • 5
    • 84872479464 scopus 로고    scopus 로고
    • Enzyme replacement therapy for lysosomal diseases: Lessons from 20 years of experience and remaining challenges
    • Desnick, RJ and Schuchman, EH (2012). Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges. Annu Rev Genomics Hum Genet 13: 307-335.
    • (2012) Annu Rev Genomics Hum Genet , vol.13 , pp. 307-335
    • Desnick, R.J.1    Schuchman, E.H.2
  • 6
    • 32944476769 scopus 로고    scopus 로고
    • Enzyme replacement for lysosomal diseases
    • Brady, RO (2006). Enzyme replacement for lysosomal diseases. Annu Rev Med 57: 283-296.
    • (2006) Annu Rev Med , vol.57 , pp. 283-296
    • Brady, R.O.1
  • 7
    • 84877318308 scopus 로고    scopus 로고
    • The final frontier - Crossing the blood-brain barrier
    • Sly, WS and Vogler, C (2013). The final frontier - crossing the blood-brain barrier. EMBO Mol Med 5: 655-657.
    • (2013) EMBO Mol Med , vol.5 , pp. 655-657
    • Sly, W.S.1    Vogler, C.2
  • 8
    • 77649219162 scopus 로고    scopus 로고
    • Novel treatments and future perspectives: Outcomes of intrathecal drug delivery
    • Dickson, PI (2009). Novel treatments and future perspectives: outcomes of intrathecal drug delivery. Int J Clin Pharmacol Ther 47(suppl. 1): S124-S127.
    • (2009) Int J Clin Pharmacol Ther , vol.47 , Issue.SUPPL. 1
    • Dickson, P.I.1
  • 9
    • 77649195183 scopus 로고    scopus 로고
    • Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases
    • Hemsley, KM and Hopwood, JJ (2009). Delivery of recombinant proteins via the cerebrospinal fluid as a therapy option for neurodegenerative lysosomal storage diseases. Int J Clin Pharmacol Ther 47(suppl. 1): S118-S123.
    • (2009) Int J Clin Pharmacol Ther , vol.47 , Issue.SUPPL. 1
    • Hemsley, K.M.1    Hopwood, J.J.2
  • 10
    • 82455208854 scopus 로고    scopus 로고
    • Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis
    • Vuillemenot, BR, Katz, ML, Coates, JR, Kennedy, D, Tiger, P, Kanazono, S et al. (2011). Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis. Mol Genet Metab 104: 325-337.
    • (2011) Mol Genet Metab , vol.104 , pp. 325-337
    • Vuillemenot, B.R.1    Katz, M.L.2    Coates, J.R.3    Kennedy, D.4    Tiger, P.5    Kanazono, S.6
  • 11
    • 80053568718 scopus 로고    scopus 로고
    • Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis
    • Xu, S, Wang, L, El-Banna, M, Sohar, I, Sleat, DE and Lobel, P (2011). Large-volume intrathecal enzyme delivery increases survival of a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 19: 1842-1848.
    • (2011) Mol Ther , vol.19 , pp. 1842-1848
    • Xu, S.1    Wang, L.2    El-Banna, M.3    Sohar, I.4    Sleat, D.E.5    Lobel, P.6
  • 12
    • 41149092265 scopus 로고    scopus 로고
    • Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis
    • Chang, M, Cooper, JD, Sleat, DE, Cheng, SH, Dodge, JC, Passini, MA et al. (2008). Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis. Mol Ther 16: 649-656.
    • (2008) Mol Ther , vol.16 , pp. 649-656
    • Chang, M.1    Cooper, J.D.2    Sleat, D.E.3    Cheng, S.H.4    Dodge, J.C.5    Passini, M.A.6
  • 13
    • 84855597543 scopus 로고    scopus 로고
    • Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier
    • Pardridge, WM and Boado, RJ (2012). Reengineering biopharmaceuticals for targeted delivery across the blood-brain barrier. Meth Enzymol 503: 269-292.
    • (2012) Meth Enzymol , vol.503 , pp. 269-292
    • Pardridge, W.M.1    Boado, R.J.2
  • 14
    • 79958024590 scopus 로고    scopus 로고
    • Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA
    • Rozaklis, T, Beard, H, Hassiotis, S, Garcia, AR, Tonini, M, Luck, A et al. (2011). Impact of high-dose, chemically modified sulfamidase on pathology in a murine model of MPS IIIA. Exp Neurol 230: 123-130.
    • (2011) Exp Neurol , vol.230 , pp. 123-130
    • Rozaklis, T.1    Beard, H.2    Hassiotis, S.3    Garcia, A.R.4    Tonini, M.5    Luck, A.6
  • 16
    • 84877596293 scopus 로고    scopus 로고
    • A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA
    • Sorrentino, NC, D'Orsi, L, Sambri, I, Nusco, E, Monaco, C, Spampanato, C et al. (2013). A highly secreted sulphamidase engineered to cross the blood-brain barrier corrects brain lesions of mice with mucopolysaccharidoses type IIIA. EMBO Mol Med 5: 675-690.
    • (2013) EMBO Mol Med , vol.5 , pp. 675-690
    • Sorrentino, N.C.1    D'Orsi, L.2    Sambri, I.3    Nusco, E.4    Monaco, C.5    Spampanato, C.6
  • 17
    • 84874271571 scopus 로고    scopus 로고
    • Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier
    • Wang, D, El-Amouri, SS, Dai, M, Kuan, CY, Hui, DY, Brady, RO et al. (2013). Engineering a lysosomal enzyme with a derivative of receptor-binding domain of apoE enables delivery across the blood-brain barrier. Proc Natl Acad Sci USA 110: 2999-3004.
    • (2013) Proc Natl Acad Sci USA , vol.110 , pp. 2999-3004
    • Wang, D.1    El-Amouri, S.S.2    Dai, M.3    Kuan, C.Y.4    Hui, D.Y.5    Brady, R.O.6
  • 18
    • 40649102937 scopus 로고    scopus 로고
    • Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII
    • Grubb, JH, Vogler, C, Levy, B, Galvin, N, Tan, Y and Sly, WS (2008). Chemically modified beta-glucuronidase crosses blood-brain barrier and clears neuronal storage in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 105: 2616-2621.
    • (2008) Proc Natl Acad Sci USA , vol.105 , pp. 2616-2621
    • Grubb, J.H.1    Vogler, C.2    Levy, B.3    Galvin, N.4    Tan, Y.5    Sly, W.S.6
  • 19
    • 84867653884 scopus 로고    scopus 로고
    • Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII
    • Huynh, HT, Grubb, JH, Vogler, C and Sly, WS (2012). Biochemical evidence for superior correction of neuronal storage by chemically modified enzyme in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 109: 17022-17027.
    • (2012) Proc Natl Acad Sci USA , vol.109 , pp. 17022-17027
    • Huynh, H.T.1    Grubb, J.H.2    Vogler, C.3    Sly, W.S.4
  • 20
    • 26844534412 scopus 로고    scopus 로고
    • Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII
    • Vogler, C, Levy, B, Grubb, JH, Galvin, N, Tan, Y, Kakkis, E et al. (2005). Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII. Proc Natl Acad Sci USA 102: 14777-14782.
    • (2005) Proc Natl Acad Sci USA , vol.102 , pp. 14777-14782
    • Vogler, C.1    Levy, B.2    Grubb, J.H.3    Galvin, N.4    Tan, Y.5    Kakkis, E.6
  • 21
    • 84863692409 scopus 로고    scopus 로고
    • Systemic administration of tripeptidyl peptidase i in a mouse model of late infantile neuronal ceroid lipofuscinosis: Effect of glycan modification
    • Meng, Y, Sohar, I, Wang, L, Sleat, DE and Lobel, P (2012). Systemic administration of tripeptidyl peptidase I in a mouse model of late infantile neuronal ceroid lipofuscinosis: effect of glycan modification. PLoS ONE 7: e40509.
    • (2012) PLoS ONE , vol.7
    • Meng, Y.1    Sohar, I.2    Wang, L.3    Sleat, D.E.4    Lobel, P.5
  • 22
    • 5744254381 scopus 로고    scopus 로고
    • Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: A preclinical animal study
    • Roces, DP, Lüllmann-Rauch, R, Peng, J, Balducci, C, Andersson, C, Tollersrud, O et al. (2004). Efficacy of enzyme replacement therapy in alpha-mannosidosis mice: a preclinical animal study. Hum Mol Genet 13: 1979-1988.
    • (2004) Hum Mol Genet , vol.13 , pp. 1979-1988
    • Roces, D.P.1    Lüllmann-Rauch, R.2    Peng, J.3    Balducci, C.4    Andersson, C.5    Tollersrud, O.6
  • 23
    • 78649483570 scopus 로고    scopus 로고
    • Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy
    • Polito, VA, Abbondante, S, Polishchuk, RS, Nusco, E, Salvia, R and Cosma, MP (2010). Correction of CNS defects in the MPSII mouse model via systemic enzyme replacement therapy. Hum Mol Genet 19: 4871-4885.
    • (2010) Hum Mol Genet , vol.19 , pp. 4871-4885
    • Polito, V.A.1    Abbondante, S.2    Polishchuk, R.S.3    Nusco, E.4    Salvia, R.5    Cosma, M.P.6
  • 24
    • 83755206474 scopus 로고    scopus 로고
    • A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain
    • Sarkar, G, Curran, GL, Mahlum, E, Decklever, T, Wengenack, TM, Blahnik, A et al. (2011). A carrier for non-covalent delivery of functional beta-galactosidase and antibodies against amyloid plaques and IgM to the brain. PLoS ONE 6: e28881.
    • (2011) PLoS ONE , vol.6
    • Sarkar, G.1    Curran, G.L.2    Mahlum, E.3    Decklever, T.4    Wengenack, T.M.5    Blahnik, A.6
  • 25
    • 0023220763 scopus 로고
    • Intracarotid infusions of protamine sulfate disrupt the bloodbrain barrier of rabbits
    • Strausbaugh, LJ (1987). Intracarotid infusions of protamine sulfate disrupt the bloodbrain barrier of rabbits. Brain Res 409: 221-226.
    • (1987) Brain Res , vol.409 , pp. 221-226
    • Strausbaugh, L.J.1
  • 26
    • 0027430683 scopus 로고
    • Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium
    • Pardridge, WM, Buciak, JL, Kang, YS and Boado, RJ (1993). Protamine-mediated transport of albumin into brain and other organs of the rat. Binding and endocytosis of protamine-albumin complex by microvascular endothelium. J Clin Invest 92: 2224-2229.
    • (1993) J Clin Invest , vol.92 , pp. 2224-2229
    • Pardridge, W.M.1    Buciak, J.L.2    Kang, Y.S.3    Boado, R.J.4
  • 27
    • 34247872806 scopus 로고    scopus 로고
    • Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells
    • Mahlum, E, Mandal, D, Halder, C, Maran, A, Yaszemski, MJ, Jenkins, RB et al. (2007). Engineering a noncarrier to a highly efficient carrier peptide for noncovalently delivering biologically active proteins into human cells. Anal Biochem 365: 215-221.
    • (2007) Anal Biochem , vol.365 , pp. 215-221
    • Mahlum, E.1    Mandal, D.2    Halder, C.3    Maran, A.4    Yaszemski, M.J.5    Jenkins, R.B.6
  • 28
    • 5644241723 scopus 로고    scopus 로고
    • A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase i activity and progressive neurodegeneration
    • Sleat, DE, Wiseman, JA, El-Banna, M, Kim, KH, Mao, Q, Price, S et al. (2004). A mouse model of classical late-infantile neuronal ceroid lipofuscinosis based on targeted disruption of the CLN2 gene results in a loss of tripeptidyl-peptidase I activity and progressive neurodegeneration. J Neurosci 24: 9117-9126.
    • (2004) J Neurosci , vol.24 , pp. 9117-9126
    • Sleat, D.E.1    Wiseman, J.A.2    El-Banna, M.3    Kim, K.H.4    Mao, Q.5    Price, S.6
  • 29
    • 0033910620 scopus 로고    scopus 로고
    • Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: Comparison of tripeptidyl peptidase i and pepstatininsensitive protease assays
    • Sohar, I, Lin, L and Lobel, P (2000). Enzyme-based diagnosis of classical late infantile neuronal ceroid lipofuscinosis: comparison of tripeptidyl peptidase I and pepstatininsensitive protease assays. Clin Chem 46: 1005-1008.
    • (2000) Clin Chem , vol.46 , pp. 1005-1008
    • Sohar, I.1    Lin, L.2    Lobel, P.3
  • 30
    • 63649139250 scopus 로고    scopus 로고
    • Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis
    • Guhaniyogi, J, Sohar, I, Das, K, Stock, AM and Lobel, P (2009). Crystal structure and autoactivation pathway of the precursor form of human tripeptidyl-peptidase 1, the enzyme deficient in late infantile ceroid lipofuscinosis. J Biol Chem 284: 3985-3997.
    • (2009) J Biol Chem , vol.284 , pp. 3985-3997
    • Guhaniyogi, J.1    Sohar, I.2    Das, K.3    Stock, A.M.4    Lobel, P.5
  • 31
    • 34548759601 scopus 로고    scopus 로고
    • Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease
    • Cabrera-Salazar, MA, Roskelley, EM, Bu, J, Hodges, BL, Yew, N, Dodge, JC et al. (2007). Timing of therapeutic intervention determines functional and survival outcomes in a mouse model of late infantile batten disease. Mol Ther 15: 1782-1788.
    • (2007) Mol Ther , vol.15 , pp. 1782-1788
    • Cabrera-Salazar, M.A.1    Roskelley, E.M.2    Bu, J.3    Hodges, B.L.4    Yew, N.5    Dodge, J.C.6
  • 32
    • 0035397487 scopus 로고    scopus 로고
    • Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis
    • Lin, L and Lobel, P (2001). Production and characterization of recombinant human CLN2 protein for enzyme-replacement therapy in late infantile neuronal ceroid lipofuscinosis. Biochem J 357(Pt 1): 49-55.
    • (2001) Biochem J , vol.357 , Issue.PART 1 , pp. 49-55
    • Lin, L.1    Lobel, P.2
  • 33
    • 84867232376 scopus 로고    scopus 로고
    • Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice
    • Marusich, JA, Grant, KR, Blough, BE and Wiley, JL (2012). Effects of synthetic cathinones contained in "bath salts" on motor behavior and a functional observational battery in mice. Neurotoxicology 33: 1305-1313.
    • (2012) Neurotoxicology , vol.33 , pp. 1305-1313
    • Marusich, J.A.1    Grant, K.R.2    Blough, B.E.3    Wiley, J.L.4
  • 34
    • 0037196246 scopus 로고    scopus 로고
    • A simple method to measure stride length as an index of nigrostriatal dysfunction in mice
    • Fernagut, PO, Diguet, E, Labattu, B and Tison, F (2002). A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. J Neurosci Methods 113: 123-130.
    • (2002) J Neurosci Methods , vol.113 , pp. 123-130
    • Fernagut, P.O.1    Diguet, E.2    Labattu, B.3    Tison, F.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.